Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 712438, 9 pages
http://dx.doi.org/10.1155/2015/712438
Research Article

Overexpression of GPC6 and TMEM132D in Early Stage Ovarian Cancer Correlates with CD8+ T-Lymphocyte Infiltration and Increased Patient Survival

1Laboratory of Gene Expression, Molecular Diagnosis and Modern Therapeutics, Department of Molecular Biology and Genetics, Faculty of Health Sciences, Democritus University of Thrace, 68100 Alexandroupolis, Greece
2Division of Genome and Gene Expression Data Analysis, Bioinformatics Institute, Agency for Science, Technology and Research (A*STAR), Singapore 138671
3Department of Oncology, University Hospital of Lausanne (CHUV), Ludwig Cancer Research Center, University of Lausanne, 1011 Lausanne, Switzerland
4Laboratory of Histology and Embryology, School of Medicine, Faculty of Health Sciences, Democritus University of Thrace, 68100 Alexandroupolis, Greece
5Division of Gynecologic Oncology, University of Pennsylvania, Philadelphia, PA 19014, USA
6Department of Clinical Oncology, School of Medicine, Faculty of Health Sciences, Democritus University of Thrace, 68100 Alexandroupolis, Greece
7Medical Statistics Lab, School of Medicine, Faculty of Health Sciences, Democritus University of Thrace, 68100 Alexandroupolis, Greece

Received 12 January 2015; Revised 27 May 2015; Accepted 28 May 2015

Academic Editor: Beric Henderson

Copyright © 2015 Athanasios Karapetsas et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Siegel, J. Ma, Z. Zou, and A. Jemal, “Cancer statistics, 2014,” CA: A Cancer Journal for Clinicians, vol. 64, no. 1, pp. 9–29, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. American Cancer Society, Cancer Facts & Figures 2013, American Cancer Society, Atlanta, Ga, USA, 2013.
  3. C. H. Holschneider and J. S. Berek, “Ovarian cancer: epidemiology, biology, and prognostic factors,” Seminars in Surgical Oncology, vol. 19, no. 1, pp. 3–10, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. D. Spentzos, D. A. Levine, M. F. Ramoni et al., “Gene expression signature with independent prognostic significance in epithelial ovarian cancer,” Journal of Clinical Oncology, vol. 22, pp. 4700–4710, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. M. J. Birrer, M. E. Johnson, K. Hao et al., “Whole genome oligonucleotide-based array comparative genomic hybridization analysis identified fibroblast growth factor 1 as a prognostic marker for advanced-stage serous ovarian adenocarcinomas,” Journal of Clinical Oncology, vol. 25, no. 16, pp. 2281–2287, 2007. View at Publisher · View at Google Scholar
  6. Y. Tanaka, H. Kobayashi, M. Suzuki et al., “Reduced bikunin gene expression as a factor of poor prognosis in ovarian carcinoma,” Cancer, vol. 98, no. 2, pp. 424–430, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. A. M. Wolf, H. Rumpold, D. Reimer, C. Marth, A. G. Zeimet, and D. Wolf, “High IL-12 p35 and IL-23 p19 mRNA expression is associated with superior outcome in ovarian cancer,” Gynecologic Oncology, vol. 118, no. 3, pp. 244–250, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. J. E. Quinn, C. R. James, G. E. Stewart et al., “BRCA1 mRNA expression levels predict for overall survival in ovarian cancer after chemotherapy,” Clinical Cancer Research, vol. 13, no. 24, pp. 7413–7420, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. L. Zhang, J. R. Conejo-Garcia, D. Katsaros et al., “Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer,” The New England Journal of Medicine, vol. 348, no. 3, pp. 203–213, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Tomšová, B. Melichar, I. Sedláková, and I. Šteiner, “Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma,” Gynecologic Oncology, vol. 108, no. 2, pp. 415–420, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. N. Leffers, M. J. M. Gooden, R. A. De Jong et al., “Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer,” Cancer Immunology, Immunotherapy, vol. 58, no. 3, pp. 449–459, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Han, M. S. Fletcher, D. L. Urbauer et al., “HLA class I antigen processing machinery component expression and intratumoral T-cell infiltrate as independent prognostic markers in ovarian carcinoma,” Clinical Cancer Research, vol. 14, no. 11, pp. 3372–3379, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. W.-T. Hwang, S. F. Adams, E. Tahirovic, I. S. Hagemann, and G. Coukos, “Prognostic significance of tumor-infiltrating T cells in ovarian cancer: a meta-analysis,” Gynecologic Oncology, vol. 124, no. 2, pp. 192–198, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. E. Sato, S. H. Olson, J. Ahn et al., “Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favourable prognosis in ovarian cancer,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, pp. 18538–18543, 2005. View at Google Scholar
  15. M. Stumpf, A. Hasenburg, M.-O. Riener et al., “Intraepithelial CD8-positive T lymphocytes predict survival for patients with serous stage III ovarian carcinomas: relevance of clonal selection of T lymphocytes,” British Journal of Cancer, vol. 101, no. 9, pp. 1513–1521, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. M. J. Callahan, Z. Nagymanyoki, T. Bonome et al., “Increased HLA-DMB expression in the tumor epithelium is associated with increased CTL infiltration and improved prognosis in advanced-stage serous ovarian cancer,” Clinical Cancer Research, vol. 14, no. 23, pp. 7667–7673, 2008. View at Publisher · View at Google Scholar
  17. B. Clarke, A. V. Tinker, C.-H. Lee et al., “Intraepithelial T cells and prognosis in ovarian carcinoma: novel associations with stage, tumor type, and BRCA1 loss,” Modern Pathology, vol. 22, no. 3, pp. 393–402, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. N. Leffers, R. S. N. Fehrmann, M. J. M. Gooden et al., “Identification of genes and pathways associated with cytotoxic T lymphocyte infiltration of serous ovarian cancer,” British Journal of Cancer, vol. 103, no. 5, pp. 685–692, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Giannakakis, A. Karapetsas, D. Dangaj et al., “Overexpression of SMARCE1 is associated with CD8+ T-cell infiltration in early stage ovarian cancer,” The International Journal of Biochemistry & Cell Biology, vol. 53, pp. 389–398, 2014. View at Publisher · View at Google Scholar
  20. B. Kornmann, N. Preitner, D. Rifat, F. Fleury-Olela, and U. Schibler, “Analysis of circadian liver gene expression by ADDER, a highly sensitive method for the display of differentially expressed mRNAs,” Nucleic acids research, vol. 29, no. 11, article E51, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Paine-Saunders, B. L. Viviano, and S. Saunders, “GPC6, a novel member of the glypican gene family, encodes a product structurally related to GPC4 and is colocalized with GPC5 on human chromosome 13,” Genomics, vol. 57, no. 3, pp. 455–458, 1999. View at Google Scholar
  22. M. Veugelers, B. De Cat, H. Ceulemans et al., “Glypican-6, a new member of the glypican family of cell surface heparan sulfate proteoglycans,” Journal of Biological Chemistry, vol. 274, no. 38, pp. 26968–26977, 1999. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Filmus, M. Capurro, and J. Rast, “Glypicans,” Genome Biology, vol. 9, article 224, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Filmus and M. Capurro, “The role of glypicans in Hedgehog signaling,” Matrix Biology, vol. 35, pp. 248–252, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. T. Y. Belenkaya, C. Han, D. Yan et al., “Drosophila Dpp morphogen movement is independent of dynamin-mediated endocytosis but regulated by the glypican members of heparan sulfate proteoglycans,” Cell, vol. 119, no. 2, pp. 231–244, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. G. K. Yiu, A. Kaunisto, Y. R. Chin, and A. Toker, “NFAT promotes carcinoma invasive migration through glypican-6,” Biochemical Journal, vol. 440, no. 1, pp. 157–166, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Erhardt, L. Czibere, D. Roeske et al., “TMEM132D, a new candidate for anxiety phenotypes: evidence from human and mouse studies,” Molecular Psychiatry, vol. 16, no. 6, pp. 647–663, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Erhardt, N. Akula, J. Schumacher et al., “Replication and meta-analysis of TMEM132D gene variants in panic disorder,” Translational Psychiatry, vol. 2, article e156, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. H. Nomoto, T. Yonezawa, K. Itoh et al., “Molecular cloning of a novel transmembrane protein MOLT expressed by mature oligodendrocytes,” The Journal of Biochemistry, vol. 134, no. 2, pp. 231–238, 2003. View at Publisher · View at Google Scholar · View at Scopus